![]() This difference was statistically more significant in the group which consisted of multiple etiologic causes (p < 0.001, r = 0.837).ĬONCLUSIONS: We found significant relation between MELD score and hepatic artery RI measurements in patients with chronic liver parenchymal disease. The Model for End-Stage Liver Disease (MELD) is a scoring system used to assess the severity of chronic liver disease (2,4,5). 3 The MELD score, as previously mentioned, helps clinicians determine how urgently a patient needs a liver transplant. RESULTS: There was statistically significant difference between MELD score and hepatic artery RI value (p < 0.001, r = 0.616). This is a prognostic scoring system based on specific laboratory measurements, used to predict 3-month mortality due to liver disease in patients 12 years of age and older. However, as the epidemiology of liver disease shifts, the MELD score is. The MELD score accurately predicts 90-day mortality risk in patients with cirrhosis and provides the first objective criteria to equitably prioritize patients on the liver transplant waiting list. Each patient’s MELD scores were calculated at the time of Doppler ultrasound performed. The advent of the MELD score has revolutionized liver transplant allocation. Patients on the LT list are prioritized based on their Model for End-Stage Liver Disease-sodium (MELD-Na) score, which is calculated from bilirubin, international normalized ratio (INR), creatinine, and sodium. Doppler ultrasonography (US) was used to assess flow velocity, pulsatility index (PI) and resistance index (RI) in the hepatic artery (HA). PATIENTS AND METHODS: Etiologic causes and hepatic artery hemodynamic parameters of 121 patients with chronic liver parenchymal disease were compared with MELD scores. OBJECTIVE: The aim of the study was to determine the relationship between the Model for End-Stage Liver Disease (MELD) score and hepatic arterial hemodynamic parameters measured via Doppler US. ![]()
0 Comments
Leave a Reply. |